[{"_id":"5641e8f3fd1ef1594b89c5d5","決算期":"2015年3月期","証券コード":"2664","会社名":"(株)カワチ薬品【2664】","会計方式":"日本方式","決算発表日":"2015年4月27日","決算月数":"12か月","売上高":"258,319百万円","営業利益":"2,814百万円","経常利益":"3,786百万円","当期利益":"-4,673百万円","EPS（一株当たり利益）":"-202.11円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,720.30円","総資産":"176,530百万円","自己資本":"86,050百万円","資本金":"13,001百万円","有利子負債":"35,371百万円","自己資本比率":"48.7%","ROA（総資産利益率）":"-2.57%","ROE（自己資本利益率）":"-5.26%","総資産経常利益率":"2.09%","日付":"2015-11-10T12:55:42.668Z"},{"_id":"5641e8f3fd1ef1594b89c5d6","決算期":"2014年3月期","証券コード":"2664","会社名":"(株)カワチ薬品【2664】","会計方式":"日本方式","決算発表日":"2014年4月30日","決算月数":"12か月","売上高":"242,684百万円","営業利益":"7,180百万円","経常利益":"8,054百万円","当期利益":"2,015百万円","EPS（一株当たり利益）":"87.16円","調整一株当たり利益":"87.08円","BPS（一株当たり純資産）":"3,964.81円","総資産":"186,508百万円","自己資本":"91,671百万円","資本金":"13,001百万円","有利子負債":"36,351百万円","自己資本比率":"49.2%","ROA（総資産利益率）":"1.13%","ROE（自己資本利益率）":"2.21%","総資産経常利益率":"4.50%","日付":"2015-11-10T12:55:42.668Z"},{"_id":"5641e8f3fd1ef1594b89c5d7","決算期":"2013年3月期","証券コード":"2664","会社名":"(株)カワチ薬品【2664】","会計方式":"日本方式","決算発表日":"2013年4月24日","決算月数":"12か月","売上高":"231,657百万円","営業利益":"8,212百万円","経常利益":"8,990百万円","当期利益":"2,066百万円","EPS（一株当たり利益）":"88.01円","調整一株当たり利益":"87.99円","BPS（一株当たり純資産）":"3,918.51円","総資産":"171,291百万円","自己資本":"90,557百万円","資本金":"13,001百万円","有利子負債":"31,239百万円","自己資本比率":"52.9%","ROA（総資産利益率）":"1.21%","ROE（自己資本利益率）":"2.28%","総資産経常利益率":"5.27%","日付":"2015-11-10T12:55:42.668Z"}]